Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis
Treatment with PI-based maintenance or consolidation therapy showed improvements in CR, ≥ VGPR, PFS, and OS in patients with MM. However, it is noteworthy that PIs-based maintenance and consolidation therapy were associated with an increased risk of ≥ grade 3 adverse events.
Authors
- Bo Yang (ORCID: https://orcid.org/0000-0001-7529-2085)
- Yang Liu (ORCID: https://orcid.org/0000-0003-4874-4773)
- Tingting Tian (ORCID: https://orcid.org/0000-0001-8767-091X)
- Feiqing Wang (ORCID: https://orcid.org/0000-0002-4297-1839)
- Juan Chen (ORCID: https://orcid.org/0000-0002-4077-2457)
- Zhenhua Liu (ORCID: https://orcid.org/0009-0008-7929-4457)
- Xu Yang (ORCID: https://orcid.org/0000-0002-5752-7255)
- Jinyang Cheng
- Dan Wu (ORCID: https://orcid.org/0000-0001-6369-9419)
- Yanju Li (ORCID: https://orcid.org/0000-0003-2924-4319)
- Bo Wei
- Zhixu He
- Xiaoshuang Yuan
Institutions
- Guiyang Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- Guizhou Provincial People's Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-12
- DOI
- https://doi.org/10.1007/s12672-025-02304-w
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Guizhou Province